A review on the potential of repurposing of metformin for colon cancer and breast cancer

A review on the potential of repurposing of metformin for colon cancer and breast cancer

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.

Détails bibliographiques
Auteur principal:	Oishy, Jannatun Noor
Autres auteurs:	Chowdhury, Namara Mariam
Format:	Thèse
Langue:	English
Publié:	BRAC University 2024
Sujets:	Metformin Drug repurposing Cancer Clinical trials Dose Breast > Cancer > Pathophysiology Drug development Metformin > History
Accès en ligne:	http://hdl.handle.net/10361/23296

Documents similaires

Drug repurposing: potential of Antimicrobial Drugs in Breast Cancer Treatment
par: Chakraborty, Anuradha
Publié: (2024)

A review on potential anticancer properties of antidiabetic drugs: metformin and sulfonylureas
par: Hossain, Tamara
Publié: (2024)

A comprehensive review on drug repurposing in cancer treatment
par: Sarkar, Onusree
Publié: (2024)

A review of Breast Cancer risk factor assessment on women in developing countries, cancer drug resistance, and Breast Cancer treatment in Bangladesh
par: Raihan, Dilraj
Publié: (2024)

A review on drug repurposing for diabetes epidemic
par: Lamia, Sadia Raisa
Publié: (2022)

Breast cancer awareness seminars
par: Anwer Khan Modern Medical College
Publié: (2016)

Breast cancer therapy through Liposomal drug delivery system
par: Ome, Nusrat Jahan
Publié: (2024)

Targeting DHFR in breast cancer: exploring expression patterns and identifying potential inhibitors through docking studies
par: Araf, Faiaz Fahim
Publié: (2024)

Pooled analysis of progression-free survival and overall survival in phase II clinical trials of breast cancer
par: Shobnam, Sohana
Publié: (2024)

Genetic innovations for breast cancer treatment : a review of gene therapy strategies and future implications
par: Hasan, Sakib
Publié: (2024)

Recent advancement on breast cancer detection and treatment
par: Rahman, Sanjida
Publié: (2023)

A review on triple-negative breast cancer and its potential treatment
par: Niasa, Jannatul Ferdous
Publié: (2023)

Targeted therapeutic options in the treatment of Breast Cancer
par: Alam, Kazi Tasnuva
Publié: (2022)

Natural products and their combinatory effects in breast cancer treatment
par: Siddique, Md. Ayman
Publié: (2021)

The impact of breast cancer on women’s lives in Bangladesh
par: Mobashera, Tayeeba Tum
Publié: (2024)

Drug repurposing: search for targeted drug candidates in the treatment of HER2 positive breast cancer
par: Yeasmin, Jahida
Publié: (2024)

Machine learning as an indicator for breast cancer prediction
par: Shadman, Tahsin Mohammed, et autres
Publié: (2019)

In vitro study on interaction of ketotifen fumarate with metformin hydrochloride
par: Sayeed, Mohammed Aktar, et autres
Publié: (2016)

Comparison of conventional doxorubicin with liposome encapsulated doxorubicin as a treatment of breast cancer-a review
par: Akter, Honufa
Publié: (2024)

RIPK pathway, as a potential target, for cancer treatment - a review
par: Jahan, Nusrat
Publié: (2024)

Use of combination of satins as antagonists of SPARC in stomach cancer: an in silico study
par: Rashed, Sadman Sakib Bin
Publié: (2019)

Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
par: Paul, Pulock
Publié: (2024)

Drug Repurposing : search for a drug having effective anticancer activity
par: Khan, Md. Arafat
Publié: (2018)

Role of statins as antagonists of SPARC in gastric cancer
par: Shahmat, Rad
Publié: (2019)

Early detection of breast cancer using machine learning
par: Fuad, Wasi Mohammad
Publié: (2019)

Pathway analysis of Disease-Gene associated network in the human breast cancer
par: Lamia
Publié: (2020)

Breast cancer in low-resource settings: Prioritizing the awareness and access programmes to overcome sociocultural and economic barriers for early detection and improved outcomes
par: Iqbal, Mohammad Shamim, et autres
Publié: (2017)

Impact of treatment size and therapy type in phase II clinical trials of non-small cell lung cancer
par: Rahman, Tasnim
Publié: (2024)

Risk of cancer associated with antihypertensive drugs
par: Iqbal, Adnan
Publié: (2024)

Breast cancer in South Asia: a Bangladeshi perspective
par: Hossain, Mohammad Sorowar, et autres
Publié: (2017)

Efficacy analysis and prediction in phase II clinical trials of non-small cell Lung Cancer
par: Hoque, Ismoth Ara
Publié: (2024)

A review on recent advances in drugs for lung cancer treatment
par: Noor, Fouzia
Publié: (2024)

Antihypertensive drugs and risk of cancer: A pharmacovigilance study
par: Rahman, Ahadina
Publié: (2018)

Breast cancer prediction using different machine learning models
par: Khandker Al- Muhaimin, et autres
Publié: (2020)

Identification of the multi-drug resistant genes in the bacteria isolated from the saliva of smoker oral cancer patients and comparative analysis with smoker normal individuals
par: Hasan, Samir, et autres
Publié: (2024)

In silico analysis revealed hsa-miR-19a-3p and hsa-miR-19b-3p as two potential inhibitors of EGF mRNA in Breast Cancer
par: Nuha, Nabiha Tahsin
Publié: (2024)

A review on nanoparticles based drug delivery in cancer treatment: advantages & challenges
par: Nahar, Kamrun
Publié: (2023)

Pooled analysis of response rate and overall survival of Tyrosine Kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
par: Karim, Samia Binte
Publié: (2024)

Therapeutic prospective of targeting calcium homeostasis in cancer – a review
par: Kamal, Tasnova
Publié: (2019)

Oncogenes: new targets in cancer treatment
par: Chowdhury, Waseka Shams
Publié: (2020)